Two Sigma Investments, LP Annovis Bio, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$11.84 - $19.78 $612,684 - $1.02 Million
-51,747 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$17.58 - $37.67 $805,498 - $1.73 Million
-45,819 Reduced 46.96%
51,747 $910,000
Q3 2021

Nov 15, 2021
BUY
$30.95 - $120.97 $3.02 Million - $11.8 Million
97,566 New
97,566 $3.1 Million

Others Institutions Holding ANVS

# of Institutions
44
Shares Held
1.15M
Call Options Held
215K
Put Options Held
934K
View Full List

About Annovis Bio, Inc.

ANVS Quotes by TradingView
  • Ticker ANVS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,163,920
  • Market Cap $58M
  • Description
  • Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...
More about ANVS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email